May 26, 2023· Comment from National Federation of Independent Business· FDA-2023-N-0743-0006
Filed on regulations.gov — full text not in the inline record.
FDANonrulemakingFDA-2023-N-0743
Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products; Availability
RIN
—
Last modified
Aug 10, 2023
Comment window
closed 1084d ago
National Federation of Independent Business filings
2
Activity
National Federation of Independent Business filed 2 comments on this docket between May 22, 2023 and May 26, 2023. 2 other organizations filed here. The comment window closed 1084d ago.
What National Federation of Independent Business filed (2)
May 22, 2023· Comment from National Federation of Independent Business· FDA-2023-N-0743-0005
NFIB (National Federation of Independent Business) comment letter of May 20, 2023, in response to Food and Drug Administration notice titled "Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products," FDA-2023-N-0743, 88 Fed. Reg. 30313 (May 11, 2023), is attached.
Abstract
OPEN
View on regulations.gov →Co-filers (2)
See everyone who commented →- National Federation of Independent BusinessTHIS ORG2 filings · confidence 97%
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
- Parenteral Drug Associationtrade assoc.1 filing · confidence 97%